Ishita Saha

Publications

• Research Article   
  Role of Serum Prostatic Acid Phosphatase on Prostate Cancer Patients
  Author(s): Jinseog Kim, Mahashweta Das, Ishita Saha, Gaurab Bhattacharyya, Sabyasachi Mukherjee, Ranjan Kumar Sahoo, Rajyalakshmi Kottapalli, Rajkumari Sanatombi Devi, Sunit Kumar Medda and Rabindra Nath Das*
  
  It is well known that serum prostatic acid phosphatase (SPAP) may have a great role on Prostate Cancer Patients (PCPs), but its effects are not clearly identified in the prostate cancer literature. The current article aims to identify the effects of SPAP on PCPs. It is derived herein that mean SPAP level is higher for PCPs (P<0.0001) and PCPs confined to bed (P=0.0794) than normal. Mean SPAP level is higher for PCPs with Bone Metastases (BM) (P<0.0001), and it is lower for cardiovascular disease history patients (CDHPs) (P=0.0188) than normal. Mean SPAP level is positively connected with estrogen level (P=0.1148) in the log-normal fitted model, while it is highly significant (P<0.0001) in the gamma fitted model. In addition, mean SPAP level is positively related with Serum Hemoglobin (SHG) (P=0.0167), size of primary tumor (P=0.0092) and study time (P=0.0463). Variance of SPA.. Read More»
  

  Abstract HTML PDF